Drugs Made In America Acquisition Corp. (DMAA) stock
DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)
Close on Nov 16, 2026Market cap $264.62MP/E –Yield –
Drugs Made In America Acquisition EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
No eps figures for Drugs Made In America Acquisition
Drugs Made In America Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?